Page last updated: 2024-10-21

pk 11195 and Constriction, Pathologic

pk 11195 has been researched along with Constriction, Pathologic in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bird, JL1
Izquierdo-Garcia, D1
Davies, JR1
Rudd, JH1
Probst, KC1
Figg, N1
Clark, JC1
Weissberg, PL1
Davenport, AP1
Warburton, EA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
In Vivo Molecular Imaging (MRI) of Atherothrombotic Lesions[NCT01418313]886 participants (Actual)Observational2011-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for pk 11195 and Constriction, Pathologic

ArticleYear
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.
    Atherosclerosis, 2010, Volume: 210, Issue:2

    Topics: Aged; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Constriction, Pathologic; Female;

2010